SrikanthVallurupalliMD

Cardiology • Little Rock, AR

Adult Congenital Heart Disease

Physician

Join to view full profile

Dr. Vallurupalli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vallurupalli's full profile

Already have an account?

Office
4301 W Markham St
# 783
Little Rock, AR 72205
Phone+1 501-686-8000

Fax+1 501-526-5148

Education & Training

University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Cardiovascular Disease, 2012 - 2015
Carle Foundation HospitalResidency, Internal Medicine, 2003 - 2007
Jawaharlal Institute of Postgraduate Medical Education and ResearchClass of 2003

Certifications & Licensure

AR State Medical License 2015 - 2026
IL State Medical License 2003 - 2014
American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

Late-onset left atrial appendage occlusion device-related thrombus attributed to mitral bioprosthetic stenosis: a case report.
Aakash Rana, Jack Xu, Hani Alturkmani, Gaurav Dhar, Srikanth Vallurupalli
European Heart Journal. Case Reports. 2024-09-01
Percutaneous pericardiocentesis using the apical approach: case series and review of the literature.
Malek Alaiwah, Ahmed Hassanin, Danish Abbasi, Hamza Rayes, Zahra Hassan
The Egyptian Heart Journal. 2024-08-16
Significance of abnormal stress electrocardiography with normal cardiac imaging during stress testing-a meta-analysis.
Munthir Mansour, Omar Alqaisi, Nitesh Gautam, Srikanth Vallurupalli
Journal of Electrocardiology. 2024-02-06

Journal Articles

PCSK9 Inhibition—A Tale of 2 Potential Treatment Opportunities
Angel Lopez-Candales, Srikanth Vallurupalli, JAMA Cardiology

Press Mentions

Thrombocytopenia Associated with Worse Outcomes After PCIMarch 16th, 2022
Researchers Discover Cholesterol Drug’s PotentialAugust 8th, 2024